An update on redifferentiation strategies for radioactive iodine-refractory differentiated thyroid carcinoma.

Due to the significant heterogeneity across studies, it will be key to harmonize research methodology and support future larger, multicenter prospective trials in order to identify the most suitable candidates for this therapeutic strategy.